Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT
Clinical trial NCT02634294 · COMPLETED
Trial details
- NCT number
- NCT02634294
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2021-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.